Angiogenesis Modulations in Health and Disease (häftad)
Format
Häftad (Paperback / softback)
Språk
Engelska
Antal sidor
206
Utgivningsdatum
2015-06-23
Upplaga
2013 ed.
Förlag
Springer
Medarbetare
Davis, Paul J. (ed.), MOUSA, SHAKER (ed.)
Illustrationer
8 Tables, black and white; X, 206 p.
Dimensioner
234 x 156 x 12 mm
Vikt
313 g
Antal komponenter
1
Komponenter
1 Paperback / softback
ISBN
9789401785150
Angiogenesis Modulations in Health and Disease (häftad)

Angiogenesis Modulations in Health and Disease

Practical Applications of Pro- and Anti-angiogenesis Targets

Häftad Engelska, 2015-06-23
1689
Skickas inom 10-15 vardagar.
Fri frakt inom Sverige för privatpersoner.
Finns även som
Visa alla 2 format & utgåvor
This book is a major update of novel targets in angiogenesis modulation, including pro- and anti-angiogenesis. There is in-depth coverage of preclinical and clinical methods and models, investigational status, and clinical applications. The impact of nanotechnology in advancing the applications of pro-and anti-angiogenesis strategies is also highlighted, along with stem cell and biotechnologies in research and development of angiogenesis modulating targets.
Visa hela texten

Passar bra ihop

  1. Angiogenesis Modulations in Health and Disease
  2. +
  3. Biological Activities of Catharanthus Roseus Leaf Extract

De som köpt den här boken har ofta också köpt Biological Activities of Catharanthus Roseus Le... av Yamini Bura, Pabba Shivakrishna (häftad).

Köp båda 2 för 2208 kr

Kundrecensioner

Har du läst boken? Sätt ditt betyg »

Fler böcker av författarna

Innehållsförteckning

Preface. 1. Angiogenesis assays: an appraisal of current techniques. 2. Survey of pro-angiogenesis strategies. 3. Angiogenesis modulation by arachidonic acid - derived lipids: positive and negative regulators of angiogenesis. 4. Pro-angiogenic activity of thyroid hormone analogues: Mechanisms, physiology and clinical prospects. 5. Actions of steroids and peptide hormones on angiogenesis. 6. Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis modulation. 7. Catecholamine neurotransmitters: an angiogenic switch in the tumor microenvironment. 8. Impact of nanotechnology on therapeutic angiogenesis. 9. Survey of anti-angiogenesis strategies. 10. Tetraiodothyroacetic acid (tetrac), nanotetrac and anti-Angiogenesis. 11. Integrin antagonists and angiogenesis. 12. Anti-angiogenesis therapy as an adjunct to chemotherapy in oncology. 13. Anti-vegf strategies in ocular angiogenesis- mediated disorders, with special emphasis on age-related macular degeneration. 14. Application of nanotechnology to targeting tumor angiogenesis for therapeutic benefit. 15. Biomarkers of response and resistance to anti-angiogenic treatment.16. Speculations on new directions in which angiogenesis may proceed. Index.